The following are excerpts from the newsletter

October 2, 2003

• Helping to remove the barriers to patient education
• How to avoid errors when prescribing leucovorin.
• Potential toxicity from the use of blue dye.
• Confusion with atropine syringes.
• Quarterly Action Agenda July-September 2003
  
  …then see the full text version of our newsletter by subscribing now.

October 16, 2003

• Survey on high-alert medications.Differences between nursing and pharmacy perspectives revealed
• How to safely use medications whose names contain suffixes, such as Wellbutrin XL and Metadate ER .
• Errors associated with thalidomide and flutamide.
• How transcription errors occur with Lantus.
• How to avoid errors with Zostrix and Zovirax.
• Results for ISMP Survey on high-alert medications
  
  …then see the full text version of our newsletter by subscribing now.

October 30, 2003

• Double-checks for endogenous and exogenous errors
• Tips on how to meet JC National Patient Safety Goals.
• How to avoid confusion between Cubicin and Cosmegen.
• The FDA's alert on Keppra and Kaletra.
• Using pharmacist medication review to avoid confusion between Indocid (indomethacin) and Endocet.
• How to avoid errors with Roxanol.
  
  …then see the full text version of our newsletter by subscribing now.